Adcetris gets speedy label expansion under FDA real-time pilot

Adcetris gets speedy label expansion under FDA real-time pilot

Source: 
BioCentury
snippet: 

FDA approved a label expansion for Adcetris brentuximab vedotin less than two weeks after Seattle Genetics Inc. (NASDAQ:SGEN) submitted the sBLA.